COMPOUND PROFILE / SMALL MOLECULES
Macimorelin.
Research draftMacimorelin is an oral ghrelin-receptor agonist used in growth-hormone diagnostic testing.
Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.
Targeted source and identity review, not a systematic review or complete regulatory audit.
Overview
Macimorelin is an oral ghrelin-receptor agonist used in growth-hormone diagnostic testing.
Mechanism
It stimulates GH release to assess the pituitary response.
Human research
Clinical diagnostic evidence concerns adult GH deficiency; this is not therapeutic hormone replacement.
Preclinical & other research
Pharmacology studies characterised the stimulation response.
Safety & unknowns
QT-related warnings and medicine interactions require the approved label.
Regulatory status
US Macrilen is a regulated diagnostic product; paediatric studies do not automatically extend its indication.
Reported use & evidence
The supplied Macimorelin profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.
Sources & references
Follow the cited records and registered research. Profiles remain research drafts.